Your browser doesn't support javascript.
loading
An overview of CDK3 in cancer: clinical significance and pharmacological implications.
Teo, Theodosia; Kasirzadeh, Sara; Albrecht, Hugo; Sykes, Matthew J; Yang, Yuchao; Wang, Shudong.
Afiliação
  • Teo T; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.
  • Kasirzadeh S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.
  • Albrecht H; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.
  • Sykes MJ; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.
  • Yang Y; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.
  • Wang S; Drug Discovery and Development, Clinical and Health Sciences, University of South Australia, Adelaide, SA 5000, Australia. Electronic address: shudong.wang@unisa.edu.au.
Pharmacol Res ; 180: 106249, 2022 06.
Article em En | MEDLINE | ID: mdl-35533805
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article